Trifecta or triple threat? The challenge of post-PCI management in patients receiving chronic oral anticoagulant therapy

MeSH terms

• Acute Coronary Syndrome / surgery*
• Atrial Fibrillation / complications*
• Coronary Restenosis / prevention & control*
• Female
• Fibrinolytic Agents / adverse effects*
• Fibrinolytic Agents / therapeutic use*
• Humans
• Male
• Myocardial Ischemia / surgery*
• Percutaneous Coronary Intervention / adverse effects*
• Percutaneous Coronary Intervention / methods*
• Postoperative Hemorrhage*
• Stents / adverse effects*
• Stroke / prevention & control*